A Randomized Placebo-Controlled, Double-Blinded, Multicenter, International Study of Durvalumab Following Stereotactic Body Radiation Therapy for the Treatment of Patients with Unresected Stage I/II Lymph Node Negative NonSmall Cell Lung Cancer (Pacific4)

A Randomized Placebo-Controlled, Double-Blinded, Multicenter, International Study of Durvalumab Following Stereotactic Body Radiation Therapy for the Treatment of Patients with Unresected Stage I/II Lymph Node Negative NonSmall Cell Lung Cancer (Pacific4)

Trial Category:
Lung
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members